Validation of DNA methylation profiling in formalin-fixed paraffin-embedded samples using the Infinium HumanMethylation450 Microarray

Epigenetics

Volumn 9, Issue 6, 2014, Pages 829-833

  Moran, Sebastián ^a   Vizoso, Miguel ^a   Martinez Cardús, Anna ^a   Gomez, Antonio ^a   Matías Guiu, Xavier ^b   Chiavenna, Sebastián M ^c   Fernandez, Andrés G ^c   Esteller, Manel ^a,d,e  

^a BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

^b UNIVERSITY OF LLEIDA   (Spain)

^c Ferrer Advanced Biotherapeutics   (Spain)

^d UNIVERSITY OF BARCELONA   (Spain)

^e INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

Author keywords

450K; DNA methylation; Epigenetics; FFPE; Infinium; Methylation; Microarray

Indexed keywords

FORMALDEHYDE; FIXATIVE; PARAFFIN;

AGAR GEL ELECTROPHORESIS; ARRAY HYBRIDIZATION; ARTICLE; BIOPSY; CPG ISLAND; DNA EXTRACTION; DNA FINGERPRINTING; DNA METHYLATION; DNA MICROARRAY; FLUOROMETRY; FROZEN SECTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; METHYLATION; MICROARRAY ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; TISSUE FIXATION; VALIDATION PROCESS; DNA REPAIR; PROCEDURES;

DNA METHYLATION; DNA REPAIR; FIXATIVES; FORMALDEHYDE; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PARAFFIN EMBEDDING;

EID: 84901752771     PISSN: 15592294     EISSN: 15592308     Source Type: Journal    
DOI: 10.4161/epi.28790     Document Type: Article

References (16)

1. Fatemi M, Pao MM, Jeong S, Gal-Yam EN, Egger G, Weisenberger DJ, Jones PA. Footprinting of mammalian promoters: use of a CpG DNA methyltransferase revealing nucleosome positions at a single molecule level. Nucleic Acids Res 2005; 33:e176; PMID:16314307; http://dx.doi.org/10.1093/nar/ gni180
2. Herman JG, Baylin SB. Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 2003; 349:2042-54; PMID:14627790; http:// dx.doi.org/10.1056/NEJMra023075
3. Esteller M, Garcia-Foncillas J, Andion E, Goodman SN, Hidalgo OF, Vanaclocha V, Baylin SB, Herman JG. Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents. N Engl J Med 2000; 343:1350-4; PMID:11070098; http://dx.doi.org/10.1056/NEJM200011093431901
4. Rakyan VK, Beyan H, Down TA, Hawa MI, Maslau S, Aden D, Daunay A, Busato F, Mein CA, Manfras B, et al. Identification of type 1 diabetes-associated DNA methylation variable positions that precede disease diagnosis. PLoS Genet 2011; 7:e1002300; PMID:21980303; http://dx.doi.org/10.1371/journal. pgen.1002300
5. Masliah E, Dumaop W, Galasko D, Desplats P. Distinctive patterns of DNA methylation associated with Parkinson disease: identification of concordant epigenetic changes in brain and peripheral blood leukocytes. Epigenetics 2013; 8:1030-8; PMID:23907097; http://dx.doi.org/10.4161/ epi.25865
6. Chestnut BA, Chang Q, Price A, Lesuisse C, Wong M, Martin LJ. Epigenetic regulation of motor neuron cell death through DNA methylation. J Neurosci 2011; 31:16619-36; PMID:22090490; http://dx.doi. org/10.1523/JNEUROSCI.1639-11.2011
7. Urdinguio RG, Sanchez-Mut JV, Esteller M. Epigenetic mechanisms in neurological diseases: genes, syndromes, and therapies. Lancet Neurol 2009; 8:1056-72; PMID:19833297; http://dx.doi. org/10.1016/S1474-4422(09)70262-5
8. Hannum G, Guinney J, Zhao L, Zhang L, Hughes G, Sadda S, Klotzle B, Bibikova M, Fan JB, Gao Y, et al. Genome-wide methylation profiles reveal quantitative views of human aging rates. Mol Cell 2013; 49:359-67; PMID:23177740; http://dx.doi. org/10.1016/j.molcel.2012.10.016
9. Heyn H, Moran S, Esteller M. Aberrant DNA methylation profiles in the premature aging disorders Hutchinson-Gilford Progeria and Werner syndrome. Epigenetics 2013; 8:28-33; PMID:23257959; http:// dx.doi.org/10.4161/epi.23366
10. Sandoval J, Mendez-Gonzalez J, Nadal E, Chen G, Carmona FJ, Sayols S, Moran S, Heyn H, Vizoso M, Gomez A, et al. A prognostic DNA methylation signature for stage I non-small-cell lung cancer. J Clin Oncol 2013; 31:4140-7; PMID:24081945; http:// dx.doi.org/10.1200/JCO.2012.48.5516
11. Asmar F, Punj V, Christensen J, Pedersen MT, Pedersen A, Nielsen AB, Hother C, Ralfkiaer U, Brown P, Ralfkiaer E, et al. Genome-wide profiling identifies a DNA methylation signature that associates with TET2 mutations in diffuse large B-cell lymphoma. Haematologica 2013; 98:1912-20; PMID:23831920; http://dx.doi.org/10.3324/ haematol.2013.088740
12. Hegi ME, Diserens AC, Gorlia T, Hamou MF, de Tribolet N, Weller M, Kros JM, Hainfellner JA, Mason W, Mariani L, et al. MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 2005; 352:997-1003; PMID:15758010; http://dx.doi.org/10.1056/NEJMoa043331
13. Bibikova M, Barnes B, Tsan C, Ho V, Klotzle B, Le JM, Delano D, Zhang L, Schroth GP, Gunderson KL, et al. High density DNA methylation array with single CpG site resolution. Genomics 2011; 98:288-95; PMID:21839163; http://dx.doi.org/10.1016/j. ygeno.2011.07.007
14. Thirlwell C, Eymard M, Feber A, Teschendorff A, Pearce K, Lechner M, Widschwendter M, Beck S. Genome-wide DNA methylation analysis of archival formalin-fixed paraffin-embedded tissue using the Illumina Infinium HumanMethylation27 BeadChip. Methods 2010; 52:248-54; PMID:20434562; http:// dx.doi.org/10.1016/j.ymeth.2010.04.012
15. Sandoval J, Heyn H, Moran S, Serra-Musach J, Pujana MA, Bibikova M, Esteller M. Validation of a DNA methylation microarray for 450,000 CpG sites in the human genome. Epigenetics 2011; 6:692-702; PMID:21593595; http://dx.doi.org/10.4161/ epi.6.6.16196
16. Maksimovic J, Gordon L, Oshlack A. SWAN: Subset-quantile within array normalization for illumina infinium HumanMethylation450 BeadChips. Genome Biol 2012; 13:R44; PMID:22703947; http://dx.doi.org/10.1186/gb-2012-13-6-r44